We are live on ! Find out more
EOLS icon

Evolus

76 hedge funds and large institutions have $58.8M invested in Evolus in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

12,800% more call options, than puts

Call options by funds: $903K | Put options by funds: $7K

115% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 13

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

9% more funds holding

Funds holding: 7076 (+6)

5.13% less ownership

Funds ownership: 24.95%19.82% (-5.1%)

51% less capital invested

Capital invested by funds: $121M → $58.8M (-$61.8M)

Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
28
Reduced
13
Closed
16
Calls
$903K
Puts
$7K
Net Calls
+$896K
Net Calls Change
+$896K

EOLS Hedge Fund Activity: Q4 2018 in Review

76 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q4 2018, worth a combined $58.8M — down 51% from $121M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new EOLS positions and 16 closed out — a net gain of 6 holders — while 28 added to existing stakes and 13 trimmed.

The largest buyer was Schroder Investment Management Group, opening a new position worth an estimated $6.68M. The largest seller was PointState Capital, exiting entirely with an estimated $12.3M sold.

  • 76 institutional investors held Evolus (EOLS) as of Q4 2018, up from 70 in Q3 2018.
  • Funds reported $58.8M of Evolus stock for Q4 2018, down 51% quarter-over-quarter.
  • 22 funds opened new Evolus positions in Q4 2018 and 16 closed out, a net change of +6 holders.
  • The largest Evolus buyer in Q4 2018 was Schroder Investment Management Group, an estimated $6.68M added.
  • The largest Evolus seller in Q4 2018 was PointState Capital, an estimated $12.3M sold.

Based on aggregated 13F filings for Q4 2018.